What is the recommended treatment for Campylobacter infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Azithromycin (500 mg once daily for 3 days) is the preferred first-line treatment for Campylobacter infections due to increasing fluoroquinolone resistance. For mild to moderate cases, supportive care is recommended, including adequate hydration and electrolyte replacement. Antibiotics are generally reserved for severe cases, patients with high fever, bloody diarrhea, prolonged symptoms (more than one week), pregnancy, immunocompromised individuals, or those with systemic spread of infection.

  • Key considerations for treatment include:
    • Severity of illness
    • Presence of bloody diarrhea or high fever
    • Prolonged symptoms
    • Pregnancy or immunocompromised status
    • Systemic spread of infection
  • Alternative treatments, such as ciprofloxacin (500 mg twice daily for 3-5 days), may be used in areas with low resistance rates 1.
  • Early treatment with antibiotics can shorten the duration of symptoms and reduce bacterial shedding 1.
  • Antimotility agents like loperamide should be avoided in cases with bloody diarrhea or high fever as they may prolong bacterial exposure to the intestinal mucosa 1.
  • Probiotics may help restore normal gut flora after infection 1.
  • Patients should be advised that symptoms may persist for several weeks after the acute infection resolves, and that proper food handling and preparation are essential to prevent future infections 1. The increasing resistance of Campylobacter to fluoroquinolones, as reported in recent studies 1, supports the use of azithromycin as a first-line treatment. Additionally, the British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease also recommends azithromycin for the treatment of Campylobacter infections 1.

From the FDA Drug Label

Doxycycline is also indicated for the treatment of infections caused by the following gram-negative microorganisms: ... Campylobacter fetus infections caused by Campylobacter fetus. Infectious Diarrhea caused by ... Campylobacter jejuni, ... when antibacterial therapy is indicated.

The recommended treatment for Campylobacter infections is doxycycline or ciprofloxacin, as both drugs are indicated for the treatment of Campylobacter infections, specifically Campylobacter fetus and Campylobacter jejuni, respectively 2 3.

  • Doxycycline is effective against Campylobacter fetus.
  • Ciprofloxacin is effective against Campylobacter jejuni.

From the Research

Treatment Options for Campylobacter Infections

  • The recommended treatment for Campylobacter infections typically involves the use of antimicrobial agents, with the choice of agent depending on the severity of the infection and the patient's overall health status 4, 5, 6.
  • Azithromycin has been shown to be effective in treating Campylobacter enteritis, particularly in areas where ciprofloxacin resistance is prevalent 6.
  • Fluoroquinolones, such as ciprofloxacin, are commonly used to treat Campylobacter infections in adults, but resistance to these agents is becoming increasingly common 7, 8.
  • The use of nitrofurans and ampicillin may also be considered as alternative treatment options 4.

Considerations for Treatment

  • The emergence of multidrug resistance in Campylobacter jejuni isolates is a concern, particularly in patients with human immunodeficiency virus (HIV) infection 5.
  • The use of fluoroquinolones in veterinary medicine has been linked to the development of fluoroquinolone-resistant Campylobacter species in humans 7.
  • Judicious use of antimicrobial agents in both human and veterinary medicine is essential to preserve the efficacy of these agents 7.
  • Patients with ciprofloxacin-resistant Campylobacter infection may experience a longer duration of diarrhea compared to those with ciprofloxacin-susceptible infection 8.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988

Research

Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995

Research

Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995

Research

Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.